AI Diagnostics Mark Turning Point in Antibiotic Resistance Crisis

Antibiotic resistance is already killing over a million people annually with projections reaching 40 million deaths by 2050—making it one of the most urgent global health crises. The critical bottleneck is diagnosis: current tests take days, during which sepsis mortality increases 4-9% per hour while physicians must guess at treatments. AI diagnostics achieving 99% accuracy could enable rapid diagnosis and guide treatment selection in real-time, while simultaneously accelerating drug discovery—together representing the breakthrough moment the field has needed.